Proton Partners to open £35m facility in Liverpool
Proton Partners International, the Welsh company behind the Rutherford Cancer Centre in Newport, is to open a £35m proton cancer treatment centre in Liverpool.
The proposed Paddington Central facility, which will be called the Rutherford Cancer Centre North West, will be one of four centres built by Proton Partners International in the UK.
Operational by 2018 and able to treat hundreds of patients every year, the new facility would be located close to the new northern headquarters of the Royal College of Physicians.
Mike Moran, chief executive of Proton Partners International, said the deal was the completion of a lifetime ambition after his interest in the non-intrusive therapy was first fuelled by his brother’s cancer diagnosis.
He added: “As someone born in Liverpool, I’m genuinely thrilled Proton Partners International will be part of this exciting new chapter in the city’s history. To see the centre being located where my brother went to school, and after what he went through, is a story that’s come full circle in many ways.
“I know how important KQ Liverpool is for the city and the entire North of England in creating a site of global significance for the scientific community.
“The Rutherford Cancer Centre North West will not just benefit private patients, but we will also treat patients referred by the NHS in need of more highly specialised cancer care. We are working with global leaders in proton beam therapy – our centres will be equipped with the best technology there is.”
The deal to secure the centre was announced at MIPIM, the world’s largest property conference.
View Proton Partners’ profile here.